Baidu
map

Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapy

Zhang, SY; Zhou, DD; Zheng, C; Xiong, P; Zhu, W; Zheng, DX

Zheng, DX (corresponding author), Obio Technol Shanghai Corp Ltd, 908,Bldg 19,Ziping Rd, Shanghai 201321, Peoples R China.

MOLECULAR THERAPY-ONCOLYTICS, 2021; 21 (): 329

Abstract

Acute lymphoblastic leukemia (ALL) is an aggressive hemato-logical neoplasm resulting from immature lymphoid precursors. An antibody-drug conjugate (A......

Full Text Link


Baidu
map
Baidu
map
Baidu
map